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Abstract: The Gram-negative bacterium Pseudomonas aeruginosa, a ubiquitous 
human opportunistic pathogen, has developed resistances to multiple antibiotics. It 
uses its primary native siderophore, pyoverdine, to scavenge the iron essential to its 
growth in the outside medium and transport it back into its cytoplasm. The FpvA 
receptor on the bacterial outer membrane recognizes and internalizes pyoverdine 
bearing its iron payload, but can also bind pyoverdines from other Pseudomonads or 
synthetic analogues. Pyoverdine derivatives could therefore be used as vectors to 
deliver antibiotics into the bacterium. In this study, we use molecular dynamics and 
free energy calculations to characterize the mechanisms and thermodynamics of the 
recognition of the native pyoverdines of P. aeruginosa and P. fluorescens by FpvA. 
Based on these results, we delineate the features that pyoverdines with high affinity 
for FpvA should possess. In particular, we show that (i) the dynamics and interaction 
of the unbound pyoverdines with water should be optimized with equal care as the 
interface contacts in the complex with FpvA; (ii) the C-terminal extremity of the 
pyoverdine chain, which appears to play no role in the bound complex, is involved in 
the intermediate stages of recognition; and (iii) the length and cyclicity of the 
pyoverdine chain can be used to fine-tune the kinetics of the recognition mechanism. 
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Introduction 
 
Pyoverdines (PVDs) are fluorescent siderophore molecules synthetized by Gram-
negative bacteria, such as the human opportunistic pathogen Pseudomonas 
aeruginosa, to act as their principal source of iron. In P. aeruginosa, the precursor of 
PVD is formed in the bacterial cytoplasm via nonribosomal peptide synthesis, by 
specific multi-enzymatic complexes called siderosomes.1 It is subsequently exported 
into the periplasm, where it undergoes maturation2, and excreted into the outside 
medium by the efflux pump PvdR-OpmQ.3 The very strong affinity of PVD for ferric 
(Fe3+) ions effectively enables this molecule to “rob” other binders of this ion by 
displacing the binding equilibrium in its favor, which permits the scavenging of ferric 
ions even in the most iron-depleted environments. The PVD/Fe3+ complex is then 
recognized by the TonB-dependent transporter FpvA (with additional minor 
contributions from transporter FpvB)4 and internalized into the periplasm.5-7 There, 
Fe3+ is reduced to Fe2+ and transported into the cytoplasm,8 while PVD is recycled 
back to the exterior medium.9,10 In addition to its role as iron scavenger, PVD plays 
an active role in the pyoverdine cell-surface signaling system (CSS) which senses 
extracellular stimuli, transduces the signal to the cytoplasm, and regulates the 
expression of stimuli-related genes (including those responsible for the biosynthesis of 
pyoverdine itself); as such, PVD participates in complex regulatory networks 
involving virulence and cell-to-cell interactions.11 Finally, the electron transfer 
capabilities and fluorescence properties of PVD also mark it out as a promising 
scaffold for biosensors, as was recently demonstrated for the rapid detection of 
pesticides in water.12  
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On its own, P. aeruginosa is responsible for 14% of hospital-acquired infections, 
where it affects immunodepressed patients,13 and is the principal cause of fatal lung 
decline in patients suffering from cystic fibrosis.14 It has acquired a resistance to 
numerous antibiotics15 and is rapidly evolving into a major public health problem 
with dire economical consequences.16 The incentive to find new therapeutic avenues 
against P. aeruginosa is therefore quite strong. A promising approach toward this 
goal is to take advantage of the fact that the FpvA transporter is specific not only to 
its endogenous pyoverdine PVDI, but is also able to bind and/or transport 
pyoverdines produced by other Pseudomonads17,18, as well as modified pyoverdines  
such as antibiotic-PVD conjugates19,20 or photoactivatable PVD analogues.21 The 
recognition of multiple iron scavengers benefits P. aeruginosa in the context of 
competitive growth under conditions of iron deprivation,22 but can potentially be 
used to conceive PVD analogues able to convey an antibiotic into the microorganism 
using a Trojan horse strategy, or to bind to FpvA in a non-reversible manner, 
blocking any further recognition and transport of the siderophore. However, this can 
only be achieved if the determinants of PVD recognition by FpvA are clearly 
understood. In particular, conformational transitions in both ligand and receptor that 
are known to occur during the binding of many known PVDs to FpvA suggest a 
possible effect of the flexibility of both molecules on the recognition mechanism.  
In this study, we apply all-atom molecular dynamics simulations to the investigation 
of the mechanisms of cognate and non-cognate PVD recognition and binding by the 
FpvA receptor of P. aeruginosa. These methods provide a straightforward 
representation of the plasticity of both partners at the atomic level, but can also 
yield quantitative estimates of kinetic and thermodynamic barriers to the formation 
and dissociation of FpvA/PVD complexes that are essential for the understanding of 
the preference of FpvA for different PVDs. We use these results to suggest 
preliminary guidelines for the conception of possible antibiotic compounds targeting 
the FpvA transporter.  
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Systems under study 
More than 100 unique pyoverdines from different species and strains of Pseudomonas 
have been identified to date (see 23 and references therein); however, all share a 
number of common traits. A fluorescent chromophore, derived from 2,3-diamino-6,7-
dihydroquinoline, binds Fe3+ via its catechol function. Grafted to its C3 atom is a 
dicarboxylic acid side-chain, which is known to play a role in the biosynthesis of 
PVD.24 Finally, the N-terminus of a linear or partly cyclic polypeptide chain, specific 
to each PVD, is linked to the carbonyl function of the chromophore; it often contains 
nonstandard and/or D-handed aminoacids and interacts with Fe3+ through two 
hydroxamate or hydroxycarboxylate functions. Consequently, the ferric ion is bound 
hexavalently to PVD via 6 oxygen atoms. This study focuses on two pyoverdines in 
their iron-binding forms: PVDI, the cognate siderophore of FpvA from P. aeruginosa 
PA01, and PVDG173 from Pseudomonas fluorescens G173 (Fig. 1a/b). Both these 
ferric-pyoverdines can bind to FpvA, forming complexes whose structures have 
experimentally been resolved; however, while PVDI binds with a very high affinity of 
0.1 nM, the affinity of PVDG173 is much lower and presently unknown.17  
The outer membrane siderophore transporter FpvA (Fig. 1c) 17,25 consists of three 
domains: (i) a β-barrel domain comprising 600 aminoacids, mostly inserted into the 
outer membrane but also featuring flexible extracellular loops; (ii) a 150-residue, N-
terminal globular “plug” region obstructing the pore; (iii) a signaling domain on the 
periplasmic side and an associated TonB box sequence, which is the locus of the 
interaction with the TonB protein of the TonB-ExbB-ExbD complex located in the 
inner membrane.26 This complex harnesses the inner membrane proton-motive force 
to provide the energy required for the transport of siderophores through FpvA. In 
particular, the formation of a channel large enough to allow the passage of the bulky 
siderophore/Fe3+ complex requires the release of the plug from the β-barrel domain; 
the release mechanism is presently unknown but is expected to be energetically 
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costly, due to the dense network of hydrogen bonds and polar contacts between these 
two domains.21 
 
 
Fig. 1 The molecules under study: structural formulas of siderophores (a) PVDI and 
(b) PVDG173; (c) cartoon representation of the FpvA transporter binding PVDI 
(green: β-barrel pore; blue: plug domain; gray: TonB signal sequence; red: PVDI; 
orange: Fe3+; the periplasmic side of the pore corresponds to the bottom of the 
figure). 
 
 
 
Methods 
 
Alchemical double decoupling method 
The standard binding free energies of the studied PVDs to FpvA were computed 
using the alchemical double decoupling method.27 The goal is to compute the 
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equilibrium constant Kb associated with the binding reaction of ligand L to receptor 
R: 𝑅 + 𝐿 ⇋ 𝑅𝐿. It can be defined as 𝐾! = 𝑅𝐿 𝑅 𝐿 , where the brackets denote 
the concentration of the corresponding species. The standard binding free energy is 
defined as Δ𝐺!! = −𝑘!𝑇𝑙𝑛 𝐶!𝐾!  where kB is the Boltzmann constant, T the 
temperature and C0 the standard concentration. The computation of this value can 
be performed by considering a thermodynamical cycle, linking the endpoints of the 
binding process via a number of intermediate states (which need not possess physical 
sense) between which free energy differences can conveniently and accurately be 
computed. These states are selected to progressively “switch off” the interaction 
between the ligand and the receptor, and then progressively “switch on” the 
interaction between the ligand and the bulk solvent, using the so-called “alchemical” 
free energy perturbation approach.28 However, as the ligand is decoupled from its 
environment, it becomes able to sample larger regions of conformational space by 
escaping the position, relative rotation and conformation to which it is restricted 
inside the binding pocket. The inability to exhaustively sample this additional 
volume at every value of the “alchemical” reaction coordinate leads to hysteresis and 
convergence problems in the determination of the free energy difference between the 
reaction endpoints.29 This issue can be alleviated by introducing restraining 
potentials to control the conformation of the ligand as well as its rigid-body 
translation and rotation relative to the receptor binding site, before the alchemical 
perturbation simulation is conducted, and removing them to “release” the ligand once 
it is complete. The free energy variation for the complete binding/unbinding 
transformation can hence be decomposed into a series of steps in which the different 
types of conformational restraints on the ligand, or its interaction with its 
surroundings, are switched on or off. By separating the effects of the alchemical 
decoupling of interactions from those of the conformational restraints, better 
convergence can be achieved.30-32 
 7 
 
Fig. 2 Schematic representation of the steps performed to evaluate the binding free 
energy ∆G!"#$!  between FpvA (light partial disc) and PVD (dark wedge/hexagon, 
depending on conformation). A light grey box around FpvA or PVD denotes 
solvation. A padlock on PVD means its conformation is constrained, while a 
combination of the grounded symbol and a padlock denotes constrained rigid-body 
rotation and translation. The unbinding transformation is shown as a full arrow; 
dotted arrows correspond to alchemical transformations; dash-dotted arrows denote 
confinement or deconfinement simulations. Circled numbers identify each step. 
Abbreviations for free energy contributions: conf=conformation, rot=rotation, 
trans=translation, int=interaction, solv=solvated PVD, vac=decoupled PVD 
(vacuum). 
 
Fig. 2 depicts the complete thermodynamical cycle and its constituent steps. Starting 
from the equilibrated structure of the bound FpvA/PVD complex, PVD was 
progressively restrained in its average bound conformation (step 1, ∆G!"#$%!"#$ ). 
Translation (step 2, ∆G!"#$%!"# ) and rotation (step 3,  ∆G!"#$%!"#$% ) restraints were then 
progressively introduced. PVD was subsequently decoupled from FpvA (step 4, −∆G!"#$%!"# ) and the rotation (step 5, −∆G!"#!"# ) and translation (step 6,−∆G!"#!"#$% ) 
restraints were removed from the decoupled ligand. Starting from the equilibrated 
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structure of PVD in water, conformational restraints were introduced to bring the 
ligand into its bound conformation (step 8, ∆G!"#$!"#$). Finally, the cycle was closed by 
decoupling PVD from the solvent (step 7, −∆G!"#$!"# ), connecting with the endpoint of 
step 6. The final binding free energy can be written out as: 
 ∆G!"#$! = −∆G!"#$%!"#$ − ∆G!"#$%!"# − ∆G!"#$%!"#$% + ∆G!"#$%!"# + ∆G!"#!"# + ∆G!"#!"#$%− ∆G!"#$!"# + ∆G!"#$!"#$ (1) 
 
The decoupling simulations (steps 4 and 7) were performed bidirectionally (creation 
and annihilation) using the free energy perturbation method (see Supporting 
Information for details). The corresponding variation in free energy was then 
extracted using the Bennett acceptance ratio.33 The associated errors reported include 
both a statistical component (derived from the variance of the free energy estimator) 
and a systematic component (which arises from the finite length of the simulations 
and residual hysteresis effects between the creation and annihilation pathways).34 432 
ns of total simulation time per PVD were computed, and the convergence of results 
with simulation length was checked (see Supporting Information). The 
conformational restraints on PVD were imposed by applying a quadratic restraining 
potential to a collective variable defined as the root mean square deviation (RMSD) 
of the heavy atoms of PVD from their positions in the bound complex, after rigid-
body alignment on the same set of atoms. This restraint was introduced (resp. 
removed) over 30 ns by coupling its action to a parameter λ, which was varied from 0 
(no restraint) to 1 (full restraint) (resp. from 1 to 0). The restraining free energy was 
then computed by integrating the derivative of the system’s energy with respect to λ. 
As before, the statistical error was computed from the variance of the derivatives 
corrected for correlation times,35 while the systematic error due to the discretization 
of the biasing coordinate was estimated from the residual hysteresis between the 
forward and reverse transformations.36 The rotation restraint was implemented by 
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acting on the angle of the optimal rotation superimposing the heavy atoms of PVD 
onto their position in the bound complex. The translation restraint acted upon the 
distance from the center of mass of PVD to the center of mass of the FpvA active 
site. As for the conformational restraint, the free energy contributions and errors 
associated with the translational and rotational restraints were evaluated by 
integrating the derivative of the energy with respect to the transition parameter λ, 
which was varied from 0 to 1 or 1 to 0 over 15 ns. It should be mentioned that 
systematic errors arise from multiple sources of different nature, some of which (e.g., 
persistent long-time correlations, forcefield and integration issues…) are very difficult 
to evaluate;37 however, the use of a thermodynamical cycle raises the chance that 
they cancel out at least partially.27 
 
Minimal distance restraint 
The minimum distance restraint methodology and its parameters are described in 
detail in earlier publications38,39 and will only be outlined here. The restraint imposes 
a minimum distance between two non-overlapping groups of atoms by acting on all 
atom pairs (with one atom in each group) according to the following biasing 
potential: E = E!!,!!!!!"# = k d! − d!"# !!,!!!!!"#  (2) 
 
 
where index i identifies atom pairs and di is the Euclidean distance between the 
atoms of pair i. The minimum separation dmin and force constant k are user-defined 
parameters. The overall biasing potential acting on the system is the sum of the 
individual contributions of all possible pairs of atoms. To avoid the two groups of 
atoms from drifting apart from each other when di ≥ dmin  ∀i , a similar quadratic 
penalty is imposed on the closest pair of atoms only: 
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 E = k d! − d!"# !, d! = min d!  (3) 
 
In turn, the biasing forces are computed as the negative gradient of the potential and 
added to those derived from the force field. A double-cutoff scheme is used for the 
efficient culling of distant atom pairs (numerous when large groups of atoms are 
constrained), preserving optimal scalability compared to an equivalent, unbiased 
molecular dynamics simulation. In this framework, a margin region surrounds the 
restrained region; atoms in the margin are not restrained (being farther apart than 
the user-specified minimum distance), but monitored for entry into the restrained 
region, whereas other atoms are simply ignored. The extension of the margin beyond 
the restrained region was chosen to be 2 Å, and the list of monitored atom pairs was 
rebuilt every ten integration steps. These values struck the best balance between 
accuracy and computational cost (which increased by less than 5% compared to the 
corresponding unbiased simulation). The minimum distance restraint is implemented 
in C++ as a dynamically linked library and interfaced to the NAMD 2.9 molecular 
dynamics package40 using Tcl bindings. The restraint software is available from the 
authors upon request.  
The two atom groups employed to control the dissociation of the FpvA/PVD 
complexes were the PVD heavy atoms on the one hand, and the heavy atoms of the 
PVD binding site of FpvA on the other (residues 200, 204, 213, 228, 230-231, 362, 
391, 431, 444, 446, 448, 597, 599, 600). For each of the two complexes under study 
(FpvA/PVDI and FpvA/PVDG173), unbinding simulations were started from the 
structure with the smallest RMSD to the average geometry observed during the 
unbiased “production” simulation (which had an interpartner distance of 
approximately 2.6 Å in both cases). From there, 23 simulations of 9 ns each (of which 
the first ns was discarded for equilibration) were sequentially performed, increasing 
the interpartner distance from 2.6 to 5.0 Å in steps of 0.1 Å (amounting to a total of 
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184 ns effective simulation time for each complex). Each simulation was started from 
the endpoint of the previous one. The free energy profile (or potential of mean force) 
along the minimum distance coordinate was obtained from the combined population 
densities of the simulation windows and the instantaneous values of the biasing 
potential, using the weighted histogram analysis method (WHAM).41 Error estimates 
and convergence assessments were performed as detailed in Supporting Information. 
 
System setup 
The starting structures for apo-FpvA, FpvA/PVDI and FpvA/PVDG173 were taken 
from the Protein Data Bank (id. 2W75, 2W16 and 2W6U, respectively). Starting 
geometries for the isolated pyoverdines were also taken from these PDB entries, for 
lack of available solution structures. Geometrical parameters and atomic charges for 
the standard amino acid residues of the siderophores were taken from the 
AMBER99SB force field.42 For the nonconventional residues (chromophore, ornithine 
derivatives and aminoacids with isopeptide side-chain bonds), additional 
parameterization was required and proceeded as follows. Geometrical parameters 
were taken from the AMBER99SB force field where available and from GAFF43 
otherwise. Charge derivation was performed by combining the RESP method with a 
systematic fragment-based approach, as implemented in RED44 and RED-Server.45 
Ferric iron was treated as ionically bound to the siderophores, rather than restrained 
using bond potentials, and was imposed a formal charge value of +3. Van der Waals 
parameters for iron were those used by Giammona.46 The FpvA protein residues were 
described using AMBER99SB.  
All structures were placed in a truncated octahedral box extending at least 10 Å from 
the molecular surface and solvated with TIP3P47 water, K+ and Cl- ions (using the 
Joung-Cheatham monovalent ion parameters48) in the proportions of a 0.15 M KCl 
solution. The systems were minimized to convergence. Positional restraints of 5 kcal 
mol-1 Å-2 were imposed on the solute heavy atoms, and the temperature of the 
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systems was raised from 0 to 300 K over 1 ns. The restraints were progressively 
scaled down over 500 ps and the systems were simulated without restraints for a 
further 2 ns, before production runs of 50 ns each were begun. 
 
Molecular dynamics simulations – general protocol 
Molecular dynamics simulations were performed using NAMD 2.940 on a local 
distributed-memory cluster, the MeCS computing platform at Université de Picardie 
– Jules Verne, and the Turing BlueGene/Q supercomputer at IDRIS, CNRS. The use 
of a 2 fs integration time step was made possible by constraining all hydrogen-
containing chemical bonds. Constant pressure (1 bar) and temperature (300 K) were 
imposed using Langevin dynamics (5 ps-1 damping coefficient)49 and Nosé-Hoover 
Langevin piston (period 200 ps, decay 100 ps).50 Boundary conditions were applied, 
and long-range electrostatics were computed every two steps using the Particle Mesh 
Ewald method51 with a real-space cutoff of 10 Å inside a multiple-time stepping 
scheme. 
 
Molecular docking protocol 
Flexible docking calculations of PVD/Fe onto FpvA were carried out using Autodock 
Vina52 interfaced with Pymol/Autodock.53 The coordinates of the receptor and 
siderophores, taken from the PDB as previously explained, were converted into the 
PDBQT format using MGLTools.54 The crystal structure of the FpvA/PVDI 
complex was taken as the reference system. The explored volume was defined as a 
cube with an edge length of 60 Å and centered on the siderophore binding site, and 
discretized using a point grid with a spacing of 0.375 Å. The docking poses were 
ranked according to their scores (which attempt to mimic binding free energies); 
indeed, the top scoring hit for PVDI corresponded to a conformation which was near-
perfectly superimposable onto the corresponding experimental structure of the 
FpvA/PVDI complex. 
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Miscellaneous 
Poisson-Boltzmann calculations were performed using APBS.55 The interface contacts 
between FpvA and PVD along the dissociation pathways were obtained using 
INTERVOR.56 Mutual information analyses were carried out with Scikit-learn.57 All 
molecular graphics were produced using VMD.58 All plots and figures were generated 
with Matplotlib.59 
 
Results 
 
Simulating PVDI, PVDG173 and FpvA 
In this study, we have chosen to model the FpvA/PVD complexes in an explicit 
solvent environment rather than in the biologically more realistic lipopolysaccharide 
(LPS) membrane. There are several justifications to this choice. Foremost is the 
crucial dependence of the convergence of free energy calculations on the equilibration 
of all degrees of freedom that are orthogonal to the biased coordinates (interpartner 
distance for the separation restraint method, coupling of the ligand to its 
environment for the double decoupling scheme). The LPS membrane of Gram-
negative bacteria is known to feature collective motion on very long timescales, which 
forced Kirschner and coworkers60 to simulate the system at an artificially high 
temperature of 350 K to achieve adequate sampling when validating their LPS 
forcefield. Water equilibration timescales being shorter, replacement of the LPS 
membrane by water will favor convergence – as will the fact that a simulation box of 
water molecules contains fewer particles and entails reduced computational 
complexity due to the use of highly optimized, specific routines for water in modern 
molecular dynamics packages. Since it is reasonable to expect that the effect of the 
membrane is similar whether or not the PVD ligand is bound to FpvA, any error 
committed is very likely to cancel out when considering free energy differences – 
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unlike convergence issues, which tend to add up from one simulation window to the 
next. Second, the recognition and binding of PVDs by FpvA involves parts of the 
transporter that do not form direct contacts with the membrane. The occurrence of 
transient loop-LPS interactions has been suggested, but not unarguably proven by 
the few studies that have tackled the subject61 – mostly because the dependence of 
these contacts on the initial positioning of the transporter inside the membrane is 
very strong, and much too costly to adequately sample. In addition, the LPS 
membrane is much more polar in nature than typical phospholipid bilayers, making 
its replacement with water less detrimental; in particular, the outer leaflet (which has 
the greatest probability of being relevant for the current study) is composed of polar 
sugars and Ca2+ ions, and has been shown both experimentally62 and 
computationally60 to be heavily permeated by water molecules. In fact, the accepted 
practice of replacing the LPS membrane by a traditional lipid bilayer (as in 
reference63, and still employed to date64) can be expected from recent studies60 to be 
at least as detrimental as our own approach. Third, very few validated force fields 
are available, to date, to describe the outer membrane of Gram-negative bacteria; the 
only all-atom candidate60 (the other alternative being united-atom65) is based on the 
GLYCAM force field66 and uses 1-4 scaling factors that renders it incompatible with 
protein force fields such as AMBER99 in all MD software except for the very latest 
version of AMBER. Our approach was further validated by showing that neither apo-
FpvA nor any of the FpvA/PVD complexes studied herein featured major structural 
deviations from their experimental structures when simulated in an aqueous medium 
for 50 ns, due to the very high rigidity of the β-barrel scaffold (see Supporting 
Information for details), proving that the membrane does not play an active role in 
the stability of the receptor. We also did not include the signaling domain and TonB 
box of FpvA in the simulated system; this is consistent with the absence of the TonB 
protein, the lack of experimental structural data for the plug-TonB box linker region, 
and the fact that only FpvA recognition and binding are studied (which occur at the 
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opposite side of the receptor and, unlike PVD internalization, do not involve the 
TonB protein). 
 
Evaluation of binding free energies 
Starting from the equilibrated structures of the FpvA receptor bound to PVDI and 
PVDG173, the alchemical double decoupling method was employed to evaluate the 
binding free energy of each PVD to the receptor. The results, and their 
decomposition into the individual steps of the thermodynamical cycle (Fig. 2) are 
presented in Table 1. A value of 14.4 kcal mol-1 was found for the binding free energy 
of PVDI, in good agreement with its experimental determination of 0.1 nM (13.7 kcal 
mol-1).17 For PVDG173, a value of 5.2 kcal mol-1 was computed. This result is all the 
more interesting since no corresponding experimental determination is available to 
date, and is fortified by the good performance of the double decoupling method on 
PVDI. It also conforms to the experimental upper threshold value of 10,000 nM (6.9 
kcal mol-1) suggested by Greenwald and coworkers.17 
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 PVDI PVDG173 Difference ∆G!"#$%!"#$  14.6 ±0.13 9.2 ± 0.08 5.4 ± 0.21 ∆G!"#$%!"#$%  0.6 ± 0.01 0.4 ± 0.01 0.2 ± 0.02 ∆G!"#$%!"#  2.2 ± 0.01 2.1 ± 0.01 0.1 ± 0.02 −∆G!"#$%!"#  157.4 ± 0.61 156.2 ± 0.55 1.2 ± 1.16 −∆G!"#!"#  -10.0 ± 0.02 -10.9 ± 0.02 0.9 ± 0.04 −∆G!"#!"#$% -8.8 ± 0.02 -9.1 ± 0.02 0.3 ± 0.04 ∆G!"#$!"#  -114.4 ± 0.32 -124.4 ± 0.31 10.0 ± 0.63 −∆G!"#$!"#$ -27.2 ± 0.15 -18.3 ± 0.14 -8.9 ± 0.29 
Total 14.4 ± 1.27 5.2 ± 1.14 9.2 ± 2.41 
Interaction 43.0 ± 0.93 31.8 ± 0.86 11.2 ± 1.79 
Flexibility -28.6 ± 0.34 -26.6 ± 0.28 -2.0 ± 0.62 
 
Table 1 Decomposition of the unbinding free energy of PVDI and PVDG173 from 
FpvA, and associated uncertainties, as obtained (and using the notations from) the 
thermodynamic cycle on Fig. 2. All entries are in kcal mol-1. 
 
The necessary summation of errors along the thermodynamical cycle accounts for 
total uncertainties of 1.1-1.3 kcal mol-1 for the computed binding free energies, which 
are quite comparable to typically reported ITC errors67 and do not put into question 
the meaningfulness of the binding free energy difference between PVDI and PVDG173. 
However, it is possible that the method would not be able to discriminate between 
minute variations upon the same PVD scaffold, if the resulting FpvA binding free 
energies should fall within 2-2.5 kcal mol-1 of each other.  
Strikingly, the decomposition of the binding free energies into their constituent terms 
shows that the higher affinity of FpvA for PVDI compared to PVDG173 is mainly due 
to the less favorable interaction of the bound conformation of PVDI with water (a 
difference of 10 kcal mol-1); the interaction of PVDI with the FpvA binding site is 
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actually only 1 kcal mol-1 more favorable than the interaction of PVDG173, which falls 
within the uncertainty range associated with this free energy difference. This is in 
agreement with the docking experiments we have performed on FpvA/PVDI and 
FpvA/ PVDG173, which predict near-equal binding free energies for both PVD 
derivatives (10.9 kcal mol-1 for PVDI and 11.2 kcal mol-1 for PVDG173). In fact, we 
have also performed docking calculations of other PVDs onto FpvA (see Table S1 in 
Supporting Information) and found docking scores to lie inside a 2 kcal mol-1 range in 
all cases, which cannot be claimed to be significant by the standards of the simplistic 
models used for the computation of docking scores. Since these scores take into 
account neither the flexibility of the ligand nor its interaction with water, they are 
comparable in nature to the alchemical decoupling simulations of PVDs from FpvA. 
Poisson-Boltzmann calculations on the bound conformations of both siderophores in 
implicit solvent also show more favorable electrostatic solvation energies for PVDG173 
than for PVDI (152.4 kcal mol-1 vs. 140.2 kcal mol-1), supporting the results of our 
alchemical free energy simulations and the dominant role of interactions with water. 
The larger conformational freedom of PVDI in solution translates into a higher 
penalty for the restraining of the molecule in its bound conformation (a difference of 
9 kcal mol-1), which is also consistent with the fact that the bound conformation of 
PVDI features a rather constrained ϕ backbone dihedral of 135° for serine 3 while the 
backbone geometry of the bound conformation of PVDG173 remains in well-populated 
regions of the Ramachandran diagram that both unbound PVD structures also favor. 
Conversely, the flexibility of PVDI in the FpvA binding site is also higher than that 
of PVDG173, such that the contributions of flexibility to the binding free energies of 
both PVDs differ by 2 kcal mol-1 only (a small, but statistically significant, difference 
compared to the 11 kcal mol-1 difference in interaction contributions). Even if it does 
not do much to discriminate between PVDI and PVDG173, the flexibility free energy 
term is in both cases quite sizeable, counterbalancing the interaction term of which it 
represents up to 85% in absolute value. 
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Free energy profiles for FpvA/PVD dissociation 
The double decoupling free energy calculations have proved able to reproduce the 
experimental binding free energy values and thresholds for the two PVDs under 
study. This is quite remarkable for such large ligands,31 even if there is a clear need 
for further validation on additional PVDs (providing the corresponding experimental 
binding free energies become available) before this good performance can 
unambiguously be confirmed. On the other hand, double decoupling simulations do 
not sample physically meaningful intermediate states; as such, they cannot provide 
information about the binding and unbinding pathway, the possible transition states 
thereupon, or the associated free energy barriers. To gain insight into these crucial 
aspects, we employed an enhanced sampling molecular dynamics method to simulate 
the controlled dissociation of the bound FpvA/PVD complexes, along a generalized 
minimal distance coordinate that reduces the bias imposed on the pathway (see 
Methods). The use of biasing forces is required to observe the dissociation of the 
complex on timescales amenable to simulation; however, the effect of the bias on the 
simulation can be removed a posteriori to recover the unbiased free energy profile 
along the dissociation coordinate. This can only be done rigorously if all variables 
orthogonal to the biased coordinate are equilibrated at every fixed value of the latter 
– yet this condition becomes increasingly difficult to meet for the rigid-body 
rotational and translational degrees of freedom of the ligand when the distance 
between partners increases. Hence, the controlled dissociation methodology is best 
suited to characterize intermediate states along the dissociation pathway and can 
rarely reach the completely dissociated state; as such, it had an appealing 
complementarity to the double decoupling scheme, which describes the endpoints of 
the complexation process but not the intermediates. 
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Fig. 3 Potential of mean force for the association and dissociation of PVDI 
(continuous line) and PVDG173 (dashed line) from FpvA along the minimum 
interpartner distance generalized coordinate (see text for details). Error bars 
correspond to twice the standard deviation in ΔG computed for the corresponding 
umbrella window (see Supporting Information for details on error estimates). 
 
The free energy profiles for the dissociation of PVDI and PVDG173 from FpvA are 
shown on Fig. 3. The complexes were separated until a plateau in the free energy 
profile was reached, which corresponds to the top of the dissociation barrier; up to 
this point, both the internal flexibility of the ligand and its rigid-body degrees of 
freedom remain contained and can be adequately sampled (see Supporting 
Information for justification). The profiles show a monotonous increase in free energy 
and plateau at values of 24.9 kcal mol-1 for PVDI and 14.3 kcal mol-1 for PVDG173. 
Supposing the existence of a single barrier between the bound and unbound states, 
and adopting the dissociated states of both complexes as the reference (i.e., zero-
point) of binding free energies, the results of the double decoupling and controlled 
dissociation methods can be combined to obtain the schematic overall free energy 
landscapes depicted in Fig. 4. The barriers to complex formation (deduced from the 
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binding free energies and the barriers to dissociation) amount to 10.5 kcal mol-1 for 
PVDI and 9.1 kcal mol-1 for PVDG173: interestingly, despite FpvA’s much higher 
affinity for PVDI, the kinetics of binding are in slight favor of the noncognate 
pyoverdine. 
 
Fig. 4 Schematic representation of the free energy landscape associated with PVD 
recognition and binding by FpvA. The free energy differences between the three 
states represented as cartoons along the abscissa (the bound state, left; the 
intermediate ‘recognition’ state, center; the dissociated state, right) are reported on 
the arrows connecting these states, for PVDI (full bars) and PVDG173 (dotted bars). 
 
Structural analysis of the binding/unbinding pathways 
To understand the structural and dynamical reasons behind this, we investigated the 
binding and unbinding pathways as revealed by the controlled dissociation 
simulations. First, we focused on the evolution of the structure and plasticity of both 
PVD ligands along the pathways. The structure of PVD at any moment in time can 
be positioned using its RMSD from the average bound and isolated conformations. 
For PVDI, these conformations are separated by a RMSD of 2.92 Å, compared to 
 21 
2.21 Å for PVDG173. The smaller RMSD difference conceals the fact that free 
PVDG173 features a labile, intramolecular hydrogen bond between serine 1 and 
aspartate 5 that was found to exist 65% of the time in our simulations, but is not 
present in the bound conformation. PVDI, in comparison, does not feature such a 
dramatic change in intramolecular interactions; as previously mentioned, the main 
difference between unbound and bound states involves partial folding of the protein 
chain around serine 3: the corresponding ϕ backbone dihedral moves away from the 
well-populated range of left-handed helix geometries (65°) in the free state, toward a 
much more constrained value of 135° in the bound state. 
 
Fig. 5 Conformational space sampled by PVDI (left) and PVDG173 (right) along the 
binding/unbinding pathway (interpartner distance, x axis), projected on the RMSD 
to the bound (y axis) and unbound (z axis) structures. The white dots represent 
individual conformations; the associated density of states is projected on each of the 
planes defined by the axes (dark blue – low density, to red – high density). 
 
The density of states sampled during our simulations in the three-dimensional 
conformational subspace defined by the interpartner distance and the RMSD values 
to the bound and unbound structures is represented on Fig. 5 for PVDI and 
PVDG173. PVDI undergoes a clear-cut conformational transition, simultaneously 
evolving structurally closer to its unbound conformation and further away from its 
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bound conformation as the interpartner distance grows, and gaining flexibility (as 
shown by the diffuseness of the RMSDfree values at large separation distances). 
However, at a distance of around 3.4 Å the density of states becomes much more 
constricted, denoting a conformational bottleneck where the ligand is expected to 
adopt a precise conformation. This was found to involve the rigidification of the 
chromophore substituent chain (via Van des Waals interactions with Val229 of 
FpvA) and the arginine sidechain (via a hydrogen bond to Tyr600), the position of 
PVDI being locked by hydrogen bond interactions of both serine moieites to Tyr661 
and Glu646 (see Fig. S6 of Supporting Information). On the unbinding free energy 
profile, this intermediate appears as a rather minute, but still quite visible, shoulder. 
PVDG173 behaves very differently: upon unbinding, it gains a much more limited 
flexibility and does not come significantly closer structurally to the geometry 
observed in water. Remarkably, the RMSD to the bound state, which increases as 
soon as the unbinding process engages, dips again at 4.3 Å where some kind of 
preselection of the bound conformation seems to occur. Apart from this, there does 
not appear to be any conformational bottlenecks to the binding and unbinding 
processes. 
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Fig. 6 Evolution of FpvA/PVD contacts along the binding pathway. Number of 
recurrent (a) and transient (b) contacts, normalized to the largest number of contacts 
observed; ratio of the number of recurrent (c) and transient (d) contacts to FpvA 
made by the peptidic chain of PVD over the number of contacts made by the 
chromophore moiety. Data entries for PVDI (resp. PVDG173) are shown as circles on 
a solid line (resp. triangles on a dotted line). 
 
To complement this analysis, we monitored the evolution of the contacts between 
each of the two PVDs and FpvA along the unbinding pathway, which we classified 
into recurrent (occurring in 50% or more of frames at the corresponding interpartner 
distance) and transient (occurring in less than 50% of frames) (Fig. 6). The number 
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of recurrent contacts made by PVDI, stable until an interpartner distance of 3.4 Å, 
undergoes a sharp decrease from 3.4 to 4 Å (Fig. 6a), compensated by the increase of 
transient contacts in the same distance range (Fig. 6b). The number of recurrent 
contacts then increases again as the barrier region is reached. Such is not the case for 
PVDG173: the number of recurrent FpvA/PVDG173 contacts decreases much more 
gradually from the onset of the process until around 4.4 Å, does not increase again in 
the barrier region, and is not compensated by a significant rise in transient contacts. 
The superior number of overall contacts (recurrent and transient) in PVDI compared 
to PVDG173, as well as the progressive rupture of permanent contacts in PVDG173 as 
opposed to the simultaneous, concerted breaking of interactions in PVDI, explains 
the higher barrier to unbinding observed for the latter. The contact map analysis also 
confirms the pivotal role of the 3.4 Å intermediate for PVDI: it is the last state on 
the unbinding pathway to retain all important ligand/receptor interactions found in 
the bound complex. At lower separation distances, PVDI is able to deform without 
durably breaking any of these contacts.  
We now divide the ligand/receptor contact map into the contacts made by the 
chromophore moiety (common to PVDI and PVDG173, as to most PVDs) and those 
made by the variable peptide chain, and investigate the relative importance of both 
classes along the PVD unbinding pathways. As already shown experimentally, 21 in 
the bound conformation of both siderophores, recurrent contacts are primarily made 
by the chromophore (Fig. 6c) – especially in the case of PVDG173. Conversely, the 
barrier area (4.1 Å and beyond) mostly features peptide-mediated contacts for PVDI, 
while chromophore-mediated contacts continue to dominate PVDG173 recognition. A 
similar trend appears for transient contacts (Fig. 6d): the transient interface between 
FpvA and PVDG173 mostly involves the chromophore at all interpartner distances, 
whereas for PVDI the contributions of chromophore and polypeptide chain are more 
balanced, with the latter becoming dominant at large separation distances. The 
crossover point for the dominance of chromophore-mediated vs. peptide-mediated 
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contacts for PVDI is located at 4.0-4.1 Å, which corresponds to the point at which 
the unbinding free energy profile suddenly plateaus. The fact that no such transition 
is observed for PVDG173 is consistent with the much more progressive plateauing of 
the corresponding potential of mean force. For further information on the unbinding 
mechanisms of both PVDs from FpvA, the reader is referred to Figs. S4 and S5 in 
Supporting Information, where detailed interpartner distance-dependent contact 
maps are provided. 
The structures of the barrier intermediate are strikingly different for FpvA/PVDI 
and FpvA/PVDG173 (Fig. 7). PVDI simultaneously contacts two of the three flexible 
loop regions forming the lid of the FpvA pore: hydrogen bonds involving PVDI-
specific aminoacids Arg2 and Thr7 (and to a lesser degree, Ser3 and Lys5) are made 
with residues 518-521 of the FpvA lid, in a way reminiscent of beta sheets; 
simultaneously, the unspecific chromophore substituent chain makes a hydrogen 
bonds to the backbone of FpvA lid aminoacids 657-659. PVDI spans the FpvA pore, 
with its long axis orthogonal to the pore axis. By contrast, in the barrier 
conformation, PVDG173 contacts FpvA via the much less flexible beta-sheet-turn 
motif centered around residue 750 of its lid region, and is aligned parallel to the pore 
axis with the chromophore residue facing toward the periplasm (an alignment that is 
very close to that of the bound conformation). Hydrogen-bond contacts are created 
between the chromophore substituent chain and Thr797, while a π-type hydrogen 
bond links the chromophore ring system to Asn747. Interestingly, the intramolecular 
hydrogen bond between Ser1 and Asp5 seen in the free state of PVDG173 does not 
exist in this barrier conformation, in good agreement with the previous observation 
that the RMSD of the siderophore to its unbound state does not notably decrease 
during the simulated dissociation process. 
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Fig. 7 Cartoon representation of the transition state structures of FpvA (grey 
cartoons, as seen from the outside of the bacterium) bound to a) PVDI and b) 
PVDG173 (per-atom-type colored sticks/pink sphere for Fe3+). Residues on the FpvA 
pore lid involved in the recognition of PVDs are represented as sticks: a) red: residues 
657-659; yellow: 518-523; b) red: 745, 747, 752. 
 
Dynamical analysis of the binding/unbinding pathways 
Finally, we analyze the correlated deformation of the siderophores and the pore lid as 
the binding proceeds. The radius of gyration was employed as the measure of 
siderophore shape. As can be seen on the inset of Fig. 8, the radius of gyration of 
PVDI diminishes notably during binding, which is due to the partial folding of the 
peptide chain around Ser3; but the shape of PVDG173 is much less affected. We now 
compute the mutual information contained in the radius of gyration on the one hand, 
and the geometry of the pore lid on the other. We quantify the latter as the area of 
the triangle formed between the backbone centers of mass of the three pore lid 
regions where recognition was seen to occur in the barrier intermediate states 
described above (residues 491-492/518-521, 657-661 and 745-752).  For both PVDs, 
the mutual information is highly variable along the binding/unbinding pathway. 
Despite this, four interpartner distance ranges in which the deformations of PVDI 
and the FpvA pore vestibule are highly correlated can be identified (centered around 
d=3.3, 3.8, 4.2 and 4.8 Å); they can be linked to already mentioned stages in the 
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binding mechanism: PVD recognition by FpvA lid loops at d=4.8 Å, switch from 
peptide chain recognition to chromophore recognition at d=4.2 Å, conformational 
bottleneck maximizing PVD-FpvA contacts at d=3.4 Å… For PVDG173, the case is 
much less clear-cut and dynamic correlations between PVD and pore vestibule shapes 
remain marginal. In addition to whether contacts to FpvA involve specific or generic 
portions of the siderophores, the difference between the specific and nonspecific 
binding mechanism can clearly be seen in the involvement (or lack thereof) of the 
flexible pore lid in the binding mechanism. 
 
Fig. 8 Mutual information (MI) between the radius of gyration of PVD (shown as 
inset) and the area of the FpvA pore vestibule (see text for details), as a function of 
interpartner distance (black: PVDI, grey: PVDG173). The area between the PVDI 
and PVDG173 MI curves is colored depending on the relative position of both curves 
(hatches on white background: MI is higher for PVDI; dots on grey background: MI 
is higher for PVDG173). 
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Discussion  
We now sum up the insights harvested from the simulations and analyses performed 
and apply them to the formulation of guidelines for the design of high-affinity PVD 
analogues. 
Our calculations indicate that the interaction of the PVDs with water is more 
important for the thermodynamic discrimination of binding candidates than the 
actual interaction with the FpvA binding pocket, which mostly involves nonspecific 
contacts. This assumption is consistent with the experimental analysis of the binding 
site interactions in the bound conformations: despite observing differences in 
interactions between high- and low-affinity pyoverdines, most notably at the interface 
between the first three aminoacids on the PVD chain and Trp599/Tyr600 on the 
FpvA L7 loop, Greenwald and coworkers acknowledge the fact that the overall 
binding affinity probably has as many influences as the numerous contacts between 
partners.17 It is also in line with Schons and coworkers’ assumption that the PVD 
peptide chain plays a more important role in the uptake of iron than in the 
recognition by FpvA.21 Finally, it is consistent with the homogeneity of molecular 
docking scores among PVDs. In addition, our simulations show that even the low-
affinity PVDG173 forms long-lasting contacts with the L7 loop of FpvA as early in the 
binding process as the high-affinity PVDI (from distances of 4.2 Å); albeit weaker in 
PVDG173 than in PVDI (long-range electrostatic interactions with the hydroxamate 
moiety and hydrophobic interactions with the chromophore vs. strong electrostatic 
interactions with Arg2), these contacts help to equalize the FpvA/PVD interaction 
energy. Consequently, achieving high binding free energies can best be pursued by 
minimizing the stability of the bound conformation of PVD in water. In PVDG173, 
the negatively charged Asp5 residue, which is not locked in a hydrogen bond in the 
bound conformation, is directly accessible to the solvent, while in PVDI the 
corresponding charged headgroup is the positive Arg2. Due to the offset between the 
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water molecule’s steric and dipole moment centers, it is well known that molecules 
with negative head charges are preferentially solvated over solutes with positive head 
charges,68 explaining the more favorable interaction of PVDG173 with water. The cost 
of reaching the bound conformation of PVD from the unbound one is also a factor 
disfavoring the thermodynamics of binding: it can be enthalpic (such as the necessity 
to break a favorable intramolecular hydrogen bond in PVDG173), entropic (such as 
the superior flexibility of PVDI limiting the statistical weight of the bound state), or 
a combination of both. A good PVD candidate should not be too flexible, nor feature 
self-interactions favoring the unbound state; it should contain positively charged 
groups rather than negatively charged ones. Among the noncognate pyoverdines 
whose affinity have been experimentally determined from binding assay 
experiments,17 this trend seems verified: PVDDSM50106, PVDATCC13525 and PVDPfl18.1 
all feature lysine-rich peptide chains whose partly cyclic nature limit conformational 
freedom; on the other hand, weak or non-binding PVDs are either noncyclic (PVDPa6, 
PVDATCC27853) and/or feature positively charged aspartate (PVDG173) or 
diaminobutyrate (PVDPa6) moieties. 
As important as the difference in free energy between the endpoints of the binding 
process is the height of the barrier that separates them, which was found to be 
sizeable in the two cases studied herein (around 10 kcal mol-1). The binding 
thermodynamics of a successful FpvA inhibitor should not be hampered by 
unfavorable kinetics; hence, optimizing the transition state structure is a necessary 
step in the conception of PVD analogues. Our study of the binding mechanisms of 
PVDI indicates that a combination of a sufficiently long peptide chain and the 
presence of hydrogen-bond donors both next to the chromophore and on the cyclic, 
C-terminal end of the peptide chain allows the siderophore to simultaneously contact 
opposite edges of the pore lid with no major deviation from its average unbound 
structure, stabilizing the barrier intermediate. This requires synchronicity between 
the movements of PVD and the pore lid and carries an entropic cost, which can 
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supposedly be minimized by PVD chains of specific sequences. Once this has been 
achieved, the rest of the binding process is facilitated by a concerted mechanism in 
which FpvA/PVD contacts that break are replaced by new ones, maintaining a near-
constant number of favorable interactions and guiding the siderophore toward its 
binding site. These interactions help compensate for the cost of partially folding the 
peptide chain around residue 3, which is the largest structural transition between the 
bound and unbound states of PVDI but also other strongly binding PVDs 
(PVDDSM50106, PVDATCC13525). Conversely, the formation of the FpvA/PVDG173 
barrier intermediate does not require correlation in the motions of the partners; 
however, PVDG173 forms fewer stabilizing contacts with the pore lid (nonspecific 
chromophore-mediated interactions) and is conformationally remote from both its 
bound and unbound structures. Furthermore, the absence of correlated motion 
renders the rest of the binding process less favorable, with a much more gradual 
buildup of favorable interactions than in PVDI. The sequence requirements favoring 
the binding kinetics can thus be summarized as follows: a hydrogen bonding side 
chain at position 2, a small residue at position 3 to favor folding, and one or more 
hydrogen bond donor residues in the C-terminal domain. The first two points had 
been suggested previously based on the analysis of PVD sequences2,17; the present 
study provides the structural reasons for them. The last point has, to date, never 
been mentioned; based on the high variability of its sequence and its lack of contacts 
with FpvA in the bound state, Greenwald and coworkers have labeled the C-terminal 
part of the PVD chain as probably irrelevant to FpvA recognition and binding. From 
the binding and unbinding mechanisms revealed by our study, we can say with some 
confidence that the C-terminal part does play a role in the intermediate stages of 
recognition; however, the relevance of such kinetics aspects compared to 
thermodynamics has yet to be investigated. Additionally, the length of the peptide 
chain appears as important in forming stable recognition intermediates as the 
availability of hydrogen-bonding groups in the C-terminal region. On this aspect, the 
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kinetics and thermodynamics requirements diverge, the former favoring long chains 
while the latter favors short ones; cyclic side chains in PVD might have evolved as a 
way to accommodate both requirements simultaneously, by limiting conformational 
freedom while preserving chain lengths.  
To further verify and generalize the criteria that a successful PVD analogue should 
possess, it will be necessary to study many more variations upon the PVD framework 
than the two species studied herein, which would imply tremendous computational 
costs with the all-atom free-energy methods employed herein. We are currently 
working on a coarse-grained approach to this problem. We hope that this work will 
spark the incentive for experimental binding assays and FRET studies69 on additional 
PVDs, providing further input and/or validation for the conception of a model of 
siderophore recogntion by the FpvA transporter. 
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